|
gptkbp:instanceOf
|
stimulant drug
|
|
gptkbp:abusePotential
|
high
|
|
gptkbp:broadcastOn
|
gptkb:Schedule_II_(US)
|
|
gptkbp:cause
|
addiction
anxiety
high blood pressure
increased heart rate
insomnia
|
|
gptkbp:chemicalClass
|
amphetamine
|
|
gptkbp:contraindication
|
gptkb:cardiovascular_disease
hypertension
glaucoma
hyperthyroidism
|
|
gptkbp:discoveredBy
|
gptkb:Lazăr_Edeleanu
|
|
gptkbp:discoveredIn
|
1887
|
|
gptkbp:effect
|
euphoria
decreased appetite
increased alertness
increased concentration
|
|
gptkbp:excretion
|
kidneys
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Amphetamines
|
|
gptkbp:legalStatus
|
controlled substance
|
|
gptkbp:mainStreet
|
speed
bennies
uppers
dexies
|
|
gptkbp:mechanismOfAction
|
increases dopamine release
increases norepinephrine release
inhibits reuptake of dopamine and norepinephrine
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:overdoseSymptoms
|
cardiac arrest
seizures
hallucinations
agitation
|
|
gptkbp:relatedTo
|
gptkb:ephedrine
gptkb:methylphenidate
cathinone
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
intranasal
|
|
gptkbp:type
|
gptkb:lisdexamfetamine
gptkb:dextroamphetamine
amphetamine
|
|
gptkbp:usedFor
|
treatment of ADHD
treatment of narcolepsy
|
|
gptkbp:usedIllegallyFor
|
weight loss
performance enhancement
recreational purposes
|
|
gptkbp:bfsParent
|
gptkb:Schedule_III_(Canada)
gptkb:List_I_(Canada)
gptkb:Eve_6_(album)
|
|
gptkbp:bfsLayer
|
7
|